| Insideraktier | 11 690 268 shares |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Nettoantalet insiders som köper (rankning)
N/A
Nettoantalet insiders som köper är den totala mängden insiders som säljer minus det totala antalet insiders som säljer under de senaste 90 dagarna. Percentilrankningen visas här (intervall från 0 till 100%).
Procent av flytande köpta av insiders (ranking)
N/A
Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Icosavax, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i ICVX / Icosavax, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i ICVX / Icosavax, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-20 | 2024-02-19 | 4 | RA CAPITAL MANAGEMENT, LLC | ICVX | Common Stock | I | −638 668 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | RA CAPITAL MANAGEMENT, LLC | ICVX | Common Stock | I | −5 324 897 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | RA CAPITAL MANAGEMENT, LLC | ICVX | Common Stock | I | −5 543 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | Simpson Adam K. By family Trust | ICVX | Common Stock | I | −129 032 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | Simpson Adam K. By family Trust | ICVX | Common Stock | I | −129 032 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | Simpson Adam K. By family Trust | ICVX | Common Stock | I | −525 044 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | Simpson Adam K. | ICVX | Common Stock | D | −358 657 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | Veneman Ann M | ICVX | Common Stock | D | −2 834 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | Veneman Ann M | ICVX | Common Stock | D | −11 209 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | Cearley Cassia | ICVX | Common Stock | D | −131 799 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | FIELDS HEIDI | ICVX | Common Stock | D | −2 917 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | FIELDS HEIDI | ICVX | Common Stock | D | −11 376 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | Wassil Jim | ICVX | Common Stock | D | −7 392 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | Wassil Jim | ICVX | Common Stock | D | −3 695 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | Russo Thomas Joseph | ICVX | Common Stock | D | −39 367 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | Shiver John W. | ICVX | Common Stock | D | −2 833 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | Shiver John W. | ICVX | Common Stock | D | −8 066 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | MCDADE MARK By Qiming U.S. Healthcare Fund II, L.P. | ICVX | Common Stock | I | −3 510 228 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | MCDADE MARK | ICVX | Common Stock | D | −55 786 | 0 | ||||||
| 2024-02-20 | 2024-02-19 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | −223 980 | 0 | ||||||
| 2024-02-02 | 2024-02-01 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 15,2924 | −15 000 | −229 | 358 657 | ||||
| 2024-02-02 | 2024-02-01 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 1,0400 | 15 000 | 16 | 373 657 | ||||
| 2024-02-02 | 2024-02-01 | 4 | Simpson Adam K. By family trust | ICVX | Common Stock | I | −6 532 | 525 044 | ||||||
| 2024-01-23 | 2024-01-22 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 1,0400 | 93 227 | 97 | 358 657 | ||||
| 2024-01-23 | 2024-01-22 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 0,8400 | 4 789 | 4 | 265 430 | ||||
| 2024-01-05 | 2023-01-04 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 15,7038 | −106 373 | −1 670 | 223 980 | ||||
| 2024-01-05 | 2023-01-04 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 15,0000 | 5 972 | 90 | 330 353 | ||||
| 2024-01-05 | 2023-01-04 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 5,9000 | 11 947 | 70 | 324 381 | ||||
| 2024-01-05 | 2023-01-04 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 1,0400 | 74 648 | 78 | 312 434 | ||||
| 2024-01-05 | 2023-01-04 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 0,8400 | 13 806 | 12 | 237 786 | ||||
| 2024-01-04 | 2024-01-02 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 15,6725 | −15 000 | −235 | 260 641 | ||||
| 2024-01-04 | 2024-01-02 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 1,0400 | 15 000 | 16 | 275 641 | ||||
| 2023-12-22 | 2023-12-21 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 15,4265 | −40 000 | −617 | 260 641 | ||||
| 2023-12-22 | 2023-12-21 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 15,4444 | −50 000 | −772 | 300 641 | ||||
| 2023-12-22 | 2023-12-21 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 0,8400 | 23 343 | 20 | 350 641 | ||||
| 2023-12-22 | 2023-12-21 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 2,4700 | 40 000 | 99 | 327 298 | ||||
| 2023-12-22 | 2023-12-21 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 1,0400 | 102 574 | 107 | 287 298 | ||||
| 2023-12-22 | 2023-12-20 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 15,4571 | −62 205 | −962 | 184 724 | ||||
| 2023-12-22 | 2023-12-20 | 4 | Russo Thomas Joseph | ICVX | Common Stock | D | 15,4650 | −4 430 | −69 | 38 037 | ||||
| 2023-12-22 | 2023-12-20 | 4 | Russo Thomas Joseph | ICVX | Common Stock | D | 15,4571 | −10 753 | −166 | 42 467 | ||||
| 2023-12-22 | 2023-12-20 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 15,4571 | −11 884 | −184 | 223 980 | ||||
| 2023-12-22 | 2023-12-20 | 4 | Cearley Cassia | ICVX | Common Stock | D | 15,4571 | −7 934 | −123 | 130 694 | ||||
| 2023-12-15 | 2023-12-13 | 4 | Cearley Cassia | ICVX | Common Stock | D | 16,0053 | −8 759 | −140 | 131 200 | ||||
| 2023-08-01 | 2023-08-01 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 0,8400 | 3 000 | 3 | 246 930 | ||||
| 2023-08-01 | 2023-07-31 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 8,8615 | −3 323 | −29 | 235 864 | ||||
| 2023-08-01 | 2023-07-31 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 8,8615 | −11 788 | −104 | 243 930 | ||||
| 2023-08-01 | 2023-07-31 | 4 | Russo Thomas Joseph | ICVX | Common Stock | D | 8,8615 | −3 066 | −27 | 45 620 | ||||
| 2023-08-01 | 2023-07-31 | 4 | Cearley Cassia | ICVX | Common Stock | D | 8,8615 | −1 888 | −17 | 139 959 | ||||
| 2023-07-03 | 2023-07-03 | 4 | Holtzman Douglas | ICVX | Common Stock | D | 9,5862 | −2 095 | −20 | 290 054 | ||||
| 2023-07-03 | 2023-07-03 | 4 | Holtzman Douglas | ICVX | Common Stock | D | 8,7413 | −14 261 | −125 | 292 149 | ||||
| 2023-07-03 | 2023-07-03 | 4 | Holtzman Douglas | ICVX | Common Stock | D | 1,0400 | 16 356 | 17 | 306 410 | ||||
| 2023-05-25 | 2023-05-23 | 4 | Cearley Cassia | ICVX | Common Stock | D | 10,0000 | −10 000 | −100 | 141 847 | ||||
| 2023-04-05 | 2023-04-03 | 4 | Holtzman Douglas | ICVX | Common Stock | D | 6,5600 | −300 | −2 | 290 054 | ||||
| 2023-04-05 | 2023-04-03 | 4 | Holtzman Douglas | ICVX | Common Stock | D | 6,0785 | −20 143 | −122 | 290 354 | ||||
| 2023-04-05 | 2023-04-03 | 4 | Holtzman Douglas | ICVX | Common Stock | D | 1,0400 | 20 443 | 21 | 310 497 | ||||
| 2023-03-08 | 2023-03-06 | 4 | Cearley Cassia | ICVX | Common Stock | D | 7,7474 | −5 000 | −39 | 151 847 | ||||
| 2023-02-16 | 2023-02-15 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 1,0400 | 10 677 | 11 | 255 718 | ||||
| 2023-02-15 | 2023-02-13 | 4 | Bekiroglu Elizabeth | ICVX | Common Stock | D | 10,6926 | −5 922 | −63 | 103 007 | ||||
| 2023-02-15 | 2023-02-14 | 4 | Holtzman Douglas | ICVX | Common Stock | D | 10,1715 | −3 349 | −34 | 290 054 | ||||
| 2023-02-15 | 2023-02-13 | 4 | Holtzman Douglas | ICVX | Common Stock | D | 10,6926 | −1 522 | −16 | 293 403 | ||||
| 2023-02-15 | 2023-02-13 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 10,6926 | −7 506 | −80 | 245 041 | ||||
| 2023-02-15 | 2023-02-13 | 4 | Russo Thomas Joseph | ICVX | Common Stock | D | 10,6926 | −1 902 | −20 | 48 686 | ||||
| 2023-02-15 | 2023-02-13 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 10,6926 | −1 794 | −19 | 239 187 | ||||
| 2023-02-15 | 2023-02-13 | 4 | Cearley Cassia | ICVX | Common Stock | D | 10,6926 | −1 660 | −18 | 156 847 | ||||
| 2023-02-14 | 2022-05-31 | 5 | Russo Thomas Joseph | ICVX | Common Stock | D | 5,7700 | 1 667 | 10 | 50 588 | ||||
| 2023-02-14 | 2022-05-31 | 5 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 5,7700 | 1 667 | 10 | 240 981 | ||||
| 2023-02-14 | 2022-05-31 | 5 | Holtzman Douglas | ICVX | Common Stock | D | 5,7700 | 1 667 | 10 | 294 925 | ||||
| 2023-02-14 | 2022-05-31 | 5 | Cearley Cassia | ICVX | Common Stock | D | 5,7700 | 1 667 | 10 | 158 507 | ||||
| 2023-01-31 | 2023-01-30 | 4 | Cearley Cassia | ICVX | Common Stock | D | 0,8400 | 25 102 | 21 | 156 840 | ||||
| 2023-01-27 | 2023-01-25 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 1,0400 | 10 678 | 11 | 252 547 | ||||
| 2023-01-27 | 2023-01-25 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 0,8400 | 2 395 | 2 | 241 869 | ||||
| 2022-12-23 | 2022-12-23 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 0,8400 | 14 369 | 12 | 239 474 | ||||
| 2022-12-23 | 2022-12-21 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 8,9630 | −66 764 | −598 | 225 105 | ||||
| 2022-12-16 | 2022-12-15 | 4 | Holtzman Douglas By Stanley Holtzman | ICVX | Common Stock | I | 11,1443 | −19 648 | −219 | 2 792 | ||||
| 2022-09-09 | 2022-09-08 | 4 | Bekiroglu Elizabeth | ICVX | Common Stock | D | 4,8731 | −1 813 | −9 | 108 929 | ||||
| 2022-08-02 | 2022-08-02 | 4 | Cearley Cassia | ICVX | Common Stock | D | 6,7038 | −303 | −2 | 131 738 | ||||
| 2022-08-02 | 2022-08-01 | 4 | Cearley Cassia | ICVX | Common Stock | D | 6,6374 | −1 118 | −7 | 132 041 | ||||
| 2022-08-02 | 2022-07-29 | 4 | Cearley Cassia | ICVX | Common Stock | D | 7,1076 | −391 | −3 | 133 159 | ||||
| 2022-08-02 | 2022-08-02 | 4 | Russo Thomas Joseph | ICVX | Common Stock | D | 6,7038 | −495 | −3 | 48 921 | ||||
| 2022-08-02 | 2022-08-01 | 4 | Russo Thomas Joseph | ICVX | Common Stock | D | 6,6374 | −1 825 | −12 | 49 416 | ||||
| 2022-08-02 | 2022-07-29 | 4 | Russo Thomas Joseph | ICVX | Common Stock | D | 7,1076 | −639 | −5 | 51 241 | ||||
| 2022-08-02 | 2022-08-02 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 6,7038 | −543 | −4 | 239 314 | ||||
| 2022-08-02 | 2022-08-01 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 6,6374 | −2 001 | −13 | 239 857 | ||||
| 2022-08-02 | 2022-07-29 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 7,1076 | −701 | −5 | 241 858 | ||||
| 2022-08-02 | 2022-08-02 | 4 | Holtzman Douglas | ICVX | Common Stock | D | 6,7038 | −453 | −3 | 293 258 | ||||
| 2022-08-02 | 2022-08-01 | 4 | Holtzman Douglas | ICVX | Common Stock | D | 6,6374 | −9 337 | −62 | 293 711 | ||||
| 2022-08-02 | 2022-07-29 | 4 | Holtzman Douglas | ICVX | Common Stock | D | 7,1076 | −585 | −4 | 303 048 | ||||
| 2022-08-02 | 2022-02-18 | 4 | Holtzman Douglas By Stanley Holtzman | ICVX | Common Stock | I | −20 000 | 22 440 | ||||||
| 2022-08-02 | 2022-08-02 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 6,7038 | −1 904 | −13 | 291 869 | ||||
| 2022-08-02 | 2022-08-01 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 6,6374 | −7 017 | −47 | 293 772 | ||||
| 2022-08-02 | 2022-07-29 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 7,1076 | −2 456 | −17 | 300 789 | ||||
| 2022-08-02 | 2022-08-02 | 4 | Richardson Charles E | ICVX | Common Stock | D | 6,7038 | −371 | −2 | 165 168 | ||||
| 2022-08-02 | 2022-08-01 | 4 | Richardson Charles E | ICVX | Common Stock | D | 6,6374 | −1 368 | −9 | 165 539 | ||||
| 2022-08-02 | 2022-07-29 | 4 | Richardson Charles E | ICVX | Common Stock | D | 7,1076 | −479 | −3 | 166 907 | ||||
| 2022-07-06 | 2022-07-01 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 0,8400 | 7 185 | 6 | 303 245 | ||||
| 2022-06-14 | 2022-06-10 | 4 | Wassil Jim | ICVX | Common Stock | D | 11 087 | 11 087 | ||||||
| 2022-06-14 | 2022-06-10 | 4 | Veneman Ann M | ICVX | Common Stock | D | 5 543 | 14 043 | ||||||
| 2022-06-14 | 2022-06-10 | 4 | Shiver John W. | ICVX | Common Stock | D | 2 399 | 10 899 | ||||||
| 2022-06-14 | 2022-06-10 | 4 | FIELDS HEIDI | ICVX | Common Stock | D | 5 543 | 14 293 | ||||||
| 2022-06-14 | 2022-06-10 | 4 | RA CAPITAL MANAGEMENT, LLC | ICVX | Common Stock | I | 5 543 | 5 543 | ||||||
| 2022-06-14 | 2022-06-10 | 4 | MCDADE MARK | ICVX | Common Stock | D | 5 543 | 55 786 | ||||||
| 2022-04-05 | 2022-04-01 | 4 | MCDADE MARK | ICVX | Common Stock | D | 7,1000 | 42 225 | 300 | 50 243 | ||||
| 2022-03-30 | 2022-03-28 | 4 | Simpson Adam K. | ICVX | Stock Option (Right to Buy) | D | 0,84 | −4 789 | 55 081 | |||||
| 2022-03-30 | 2022-03-28 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 0,8400 | 4 789 | 4 | 220 482 | ||||
| 2022-03-30 | 2022-03-29 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | ICVX | Common Stock | I | 4,7496 | 8 900 | 42 | 5 963 565 | ||||
| 2022-03-30 | 2022-03-28 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | ICVX | Common Stock | I | 4,5324 | 175 318 | 795 | 5 953 665 | ||||
| 2022-03-22 | 2022-03-18 | 4 | Cearley Cassia | ICVX | Stock Option (Right to Buy) | D | 0,84 | −35 137 | 27 613 | |||||
| 2022-03-22 | 2022-03-18 | 4 | Cearley Cassia | ICVX | Common Stock | D | 0,8400 | 35 137 | 30 | 133 550 | ||||
| 2022-03-09 | 2022-03-07 | 4 | Cearley Cassia | ICVX | Common Stock | D | 17,8100 | −484 | −9 | 98 413 | ||||
| 2022-03-09 | 2022-03-07 | 4 | Cearley Cassia | ICVX | Common Stock | D | 17,1300 | −9 516 | −163 | 98 897 | ||||
| 2022-02-16 | 2022-02-14 | 4 | Richardson Charles E | ICVX | Stock Option (Right to Buy) | D | 1,04 | −6 186 | 16 657 | |||||
| 2022-02-16 | 2022-02-14 | 4 | Richardson Charles E | ICVX | Stock Option (Right to Buy) | D | 0,84 | −66 375 | 43 489 | |||||
| 2022-02-16 | 2022-02-14 | 4 | Richardson Charles E | ICVX | Common Stock | D | 1,0400 | 6 186 | 6 | 167 386 | ||||
| 2022-02-16 | 2022-02-14 | 4 | Richardson Charles E | ICVX | Common Stock | D | 0,8400 | 66 375 | 56 | 161 200 | ||||
| 2022-02-14 | 2022-02-10 | 4 | Simpson Adam K. | ICVX | Stock Option (Right to Buy) | D | 17,55 | 317 866 | 317 866 | |||||
| 2022-02-14 | 2022-02-10 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 75 578 | 291 271 | ||||||
| 2022-02-14 | 2022-02-10 | 4 | Russo Thomas Joseph | ICVX | Stock Option (Right to Buy) | D | 17,55 | 74 500 | 74 500 | |||||
| 2022-02-14 | 2022-02-10 | 4 | Russo Thomas Joseph | ICVX | Common Stock | D | 17 714 | 51 880 | ||||||
| 2022-02-14 | 2022-02-10 | 4 | Kanesa-thasan Niranjan | ICVX | Stock Option | D | 17,55 | 81 950 | 81 950 | |||||
| 2022-02-14 | 2022-02-10 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 19 485 | 242 559 | ||||||
| 2022-02-14 | 2022-02-10 | 4 | Richardson Charles E | ICVX | Stock Option (Right to Buy) | D | 17,55 | 67 050 | 67 050 | |||||
| 2022-02-14 | 2022-02-10 | 4 | Richardson Charles E | ICVX | Common Stock | D | 15 942 | 94 825 | ||||||
| 2022-02-14 | 2022-02-10 | 4 | Holtzman Douglas | ICVX | Stock Option (Right to Buy) | D | 17,55 | 81 950 | 81 950 | |||||
| 2022-02-14 | 2022-02-10 | 4 | Holtzman Douglas | ICVX | Common Stock | D | 19 485 | 303 633 | ||||||
| 2022-02-14 | 2021-12-31 | 4 | Holtzman Douglas By Stanley Holtzman | ICVX | Common Stock | I | −10 000 | 42 440 | ||||||
| 2022-02-14 | 2022-02-10 | 4 | Bekiroglu Elizabeth | ICVX | Common Stock | D | 82 992 | 110 742 | ||||||
| 2022-02-14 | 2022-02-10 | 4 | Cearley Cassia | ICVX | Stock Option (Right to Buy) | D | 17,55 | 89 400 | 89 400 | |||||
| 2022-02-14 | 2022-02-10 | 4 | Cearley Cassia | ICVX | Common Stock | D | 21 256 | 108 413 | ||||||
| 2022-02-04 | 2022-02-02 | 4 | Kanesa-thasan Niranjan | ICVX | Stock Option Right to Buy) | D | 1,04 | −38 947 | 116 841 | |||||
| 2022-02-04 | 2022-02-02 | 4 | Kanesa-thasan Niranjan | ICVX | Stock Option (Right to Buy) | D | 0,84 | −13 805 | 16 317 | |||||
| 2022-02-04 | 2022-02-02 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 1,0400 | 38 947 | 41 | 221 408 | ||||
| 2022-02-04 | 2022-02-02 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 0,8400 | 13 805 | 12 | 182 461 | ||||
| 2022-01-28 | 2022-01-26 | 4 | Simpson Adam K. | ICVX | Stock Option (Right to Buy) | D | 1,04 | −73 929 | 438 605 | |||||
| 2022-01-28 | 2022-01-26 | 4 | Simpson Adam K. | ICVX | Stock Option (Right to Buy) | D | 0,84 | −16 764 | 59 870 | |||||
| 2022-01-28 | 2022-01-26 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 1,0400 | 73 929 | 77 | 215 693 | ||||
| 2022-01-28 | 2022-01-26 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 0,8400 | 16 764 | 14 | 141 764 | ||||
| 2022-01-28 | 2021-12-21 | 4 | Simpson Adam K. By family trust | ICVX | Common Stock | I | 125 000 | 129 032 | ||||||
| 2022-01-28 | 2021-12-21 | 4 | Simpson Adam K. By family trust | ICVX | Common Stock | I | 125 000 | 129 032 | ||||||
| 2022-01-28 | 2021-12-21 | 4 | Simpson Adam K. By family trust | ICVX | Common Stock | I | −125 000 | 531 576 | ||||||
| 2022-01-28 | 2021-12-21 | 4 | Simpson Adam K. By family trust | ICVX | Common Stock | I | −125 000 | 531 576 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Shiver John W. | ICVX | Stock Option (Right to Buy) | D | 22,50 | 25 500 | 25 500 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Shiver John W. | ICVX | Common Stock | D | 8 500 | 8 500 | ||||||
| 2021-11-17 | 2021-11-15 | 4 | Cearley Cassia | ICVX | Stock Option (Right to Buy) | D | 0,83 | −22 598 | 62 750 | |||||
| 2021-11-17 | 2021-11-15 | 4 | Cearley Cassia | ICVX | Common Stock | D | 0,8300 | 22 598 | 19 | 85 491 | ||||
| 2021-09-21 | 3 | Bekiroglu Elizabeth | ICVX | Common Stock | D | 27 750 | ||||||||
| 2021-08-04 | 2021-08-02 | 4 | NanoDimension III, L.P. | ICVX | Series B-1 Preferred Stock | I | 0,00 | −1 027 741 | 0 | |||||
| 2021-08-04 | 2021-08-02 | 4 | NanoDimension III, L.P. | ICVX | Series A-1 Preferred Stock | I | 0,00 | −10 400 415 | 0 | |||||
| 2021-08-04 | 2021-08-02 | 4 | NanoDimension III, L.P. | ICVX | Common Stock | D | 15,0000 | 133 334 | 2 000 | 2 883 329 | ||||
| 2021-08-04 | 2021-08-02 | 4 | NanoDimension III, L.P. | ICVX | Common Stock | D | 2 749 995 | 2 749 995 | ||||||
| 2021-08-04 | 2021-08-02 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | ICVX | Series B-1 Preferred Stock | I | −1 940 306 | 0 | ||||||
| 2021-08-04 | 2021-08-02 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | ICVX | Series B-1 Preferred Stock | I | −10 995 066 | 0 | ||||||
| 2021-08-04 | 2021-08-02 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | ICVX | Common Stock | I | 15,0000 | 171 766 | 2 576 | 638 668 | ||||
| 2021-08-04 | 2021-08-02 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | ICVX | Common Stock | I | 466 902 | 466 902 | ||||||
| 2021-08-04 | 2021-08-02 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | ICVX | Common Stock | I | 15,0000 | 2 494 900 | 37 424 | 5 140 679 | ||||
| 2021-08-04 | 2021-08-02 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | ICVX | Common Stock | I | 2 645 779 | 2 645 779 | ||||||
| 2021-08-04 | 2021-08-02 | 4 | Cormorant Asset Management, LLC See Footnotes | ICVX | Series B-1 Convertible Preferred Stock | I | −426 393 | 0 | ||||||
| 2021-08-04 | 2021-08-02 | 4 | Cormorant Asset Management, LLC See Footnotes | ICVX | Common Stock | I | 426 393 | 426 393 | ||||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Series B-1 Preferred Stock | I | 0,00 | −79 734 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Series B-1 Preferred Stock | I | 0,00 | −171 505 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Series B-1 Preferred Stock | I | 0,00 | −114 843 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Series B-1 Preferred Stock | I | 0,00 | −88 775 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Series B-1 Preferred Stock | I | 0,00 | −299 003 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Series B-1 Preferred Stock | I | 0,00 | −309 321 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Series A-1 Preferred Stock | I | 0,00 | −935 985 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Series A-1 Preferred Stock | I | 0,00 | −2 013 269 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Series A-1 Preferred Stock | I | 0,00 | −1 348 119 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Series A-1 Preferred Stock | I | 0,00 | −1 042 120 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Series A-1 Preferred Stock | I | 0,00 | −3 509 939 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Series A-1 Preferred Stock | I | 0,00 | −3 631 066 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Common Stock | I | 15,0000 | 12 368 | 186 | 256 783 | ||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Common Stock | I | 244 415 | 244 415 | ||||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Common Stock | I | 15,0000 | 26 604 | 399 | 552 333 | ||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Common Stock | I | 525 729 | 525 729 | ||||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Common Stock | I | 352 037 | 352 037 | ||||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Common Stock | I | 272 131 | 272 131 | ||||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Common Stock | I | 15,0000 | 46 381 | 696 | 962 939 | ||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Common Stock | I | 916 558 | 916 558 | ||||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Common Stock | I | 15,0000 | 47 981 | 720 | 996 169 | ||||
| 2021-08-03 | 2021-08-02 | 4 | Gould Terry P See footnotes | ICVX | Common Stock | I | 948 188 | 948 188 | ||||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Series B-1 Preferred Stock | I | 0,00 | −79 734 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Series B-1 Preferred Stock | I | 0,00 | −171 505 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Series B-1 Preferred Stock | I | 0,00 | −114 843 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Series B-1 Preferred Stock | I | 0,00 | −88 775 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Series B-1 Preferred Stock | I | 0,00 | −299 003 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Series B-1 Preferred Stock | I | 0,00 | −309 321 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Series A-1 Preferred Stock | I | 0,00 | −935 985 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Series A-1 Preferred Stock | I | 0,00 | −2 013 269 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Series A-1 Preferred Stock | I | 0,00 | −1 348 119 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Series A-1 Preferred Stock | I | 0,00 | −1 042 120 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Series A-1 Preferred Stock | I | 0,00 | −3 509 939 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Series A-1 Preferred Stock | I | 0,00 | −3 631 066 | 0 | |||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Common Stock | I | 15,0000 | 12 368 | 186 | 256 783 | ||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Common Stock | I | 244 415 | 244 415 | ||||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Common Stock | I | 15,0000 | 26 604 | 399 | 552 333 | ||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Common Stock | I | 525 729 | 525 729 | ||||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Common Stock | I | 352 037 | 352 037 | ||||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Common Stock | I | 272 131 | 272 131 | ||||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Common Stock | I | 15,0000 | 46 381 | 696 | 962 939 | ||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Common Stock | I | 916 558 | 916 558 | ||||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Common Stock | I | 15,0000 | 47 981 | 720 | 996 169 | ||||
| 2021-08-03 | 2021-08-02 | 4 | ADAMS STREET PARTNERS LLC See footnotes | ICVX | Common Stock | I | 948 188 | 948 188 | ||||||
| 2021-08-02 | 2021-07-30 | 4 | FIELDS HEIDI | ICVX | Common Stock | D | 15,0000 | 8 750 | 131 | 8 750 | ||||
| 2021-08-02 | 2021-07-30 | 4 | Veneman Ann M | ICVX | Common Stock | D | 15,0000 | 8 500 | 128 | 8 500 | ||||
| 2021-08-02 | 2021-08-02 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 15,0000 | 6 666 | 100 | 6 666 | ||||
| 2021-08-02 | 2021-07-30 | 4 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 15,0000 | 41 500 | 622 | 168 656 | ||||
| 2021-08-02 | 2021-08-02 | 4 | Sanofi Through its wholly-owned subsidiary, Aventis Inc | ICVX | Series B-1 Preferred Stock (par value, $0.0001) | I | 0,00 | −354 393 | 0 | |||||
| 2021-08-02 | 2021-08-02 | 4 | Sanofi Through its wholly-owned subsidiary, Aventis Inc | ICVX | Series A-1 Preferred Stock (par value, $0.0001) | I | 0,00 | −12 480 498 | 0 | |||||
| 2021-08-02 | 2021-08-02 | 4 | Sanofi Through its wholly-owned subsidiary, Aventis Inc. | ICVX | Common Stock (par value, $0.0001) | I | 15,0000 | 66 667 | 1 000 | 3 155 169 | ||||
| 2021-08-02 | 2021-08-02 | 4 | Sanofi Through its wholly-owned subsidiary, Aventis Inc. | ICVX | Common Stock (par value, $0.0001) | I | 3 088 502 | 3 088 502 | ||||||
| 2021-08-02 | 2021-07-30 | 4 | Russo Thomas Joseph | ICVX | Common Stock | D | 15,0000 | 32 500 | 488 | 32 500 | ||||
| 2021-08-02 | 2021-07-30 | 4 | Cearley Cassia | ICVX | Common Stock | D | 15,0000 | 27 750 | 416 | 62 893 | ||||
| 2021-08-02 | 2021-08-02 | 4 | Holtzman Douglas By Stanley Holtzman | ICVX | Series B-1 Preferred Stock | I | 0,00 | −11 602 | 0 | |||||
| 2021-08-02 | 2021-08-02 | 4 | Holtzman Douglas By Stanley Holtzman | ICVX | Series A-1 Preferred Stock | I | 0,00 | −206 323 | 0 | |||||
| 2021-08-02 | 2021-08-02 | 4 | Holtzman Douglas By Stanley Holtzman | ICVX | Common Stock | I | 52 440 | 52 440 | ||||||
| 2021-08-02 | 2021-07-30 | 4 | Holtzman Douglas | ICVX | Common Stock | D | 15,0000 | 41 500 | 622 | 282 482 | ||||
| 2021-08-02 | 2021-07-30 | 4 | Richardson Charles E | ICVX | Common Stock | D | 15,0000 | 27 750 | 416 | 78 883 | ||||
| 2021-08-02 | 2021-08-02 | 4 | Qiming U.S. Healthcare Fund II, L.P. | ICVX | Series B-1 Preferred Stock | D | 0,00 | −1 275 817 | 0 | |||||
| 2021-08-02 | 2021-08-02 | 4 | Qiming U.S. Healthcare Fund II, L.P. | ICVX | Series A-1 Preferred Stock | D | 0,00 | −12 480 498 | 0 | |||||
| 2021-08-02 | 2021-08-02 | 4 | Qiming U.S. Healthcare Fund II, L.P. | ICVX | Common Stock | D | 15,0000 | 13 333 | 200 | 3 523 561 | ||||
| 2021-08-02 | 2021-08-02 | 4 | Qiming U.S. Healthcare Fund II, L.P. | ICVX | Common Stock | D | 15,0000 | 8 018 | 120 | 3 518 246 | ||||
| 2021-08-02 | 2021-08-02 | 4 | Qiming U.S. Healthcare Fund II, L.P. | ICVX | Common Stock | D | 15,0000 | 200 000 | 3 000 | 3 510 228 | ||||
| 2021-08-02 | 2021-08-02 | 4 | Qiming U.S. Healthcare Fund II, L.P. | ICVX | Common Stock | D | 3 310 228 | 3 310 228 | ||||||
| 2021-08-02 | 2021-07-30 | 4 | Simpson Adam K. | ICVX | Common Stock | D | 15,0000 | 125 000 | 1 875 | 125 000 | ||||
| 2021-07-28 | 3 | Cearley Cassia | ICVX | Common Stock | D | 35 143 | ||||||||
| 2021-07-28 | 3 | Kanesa-thasan Niranjan | ICVX | Common Stock | D | 120 490 | ||||||||
| 2021-07-28 | 3 | Yamada Tadataka | ICVX | Common Stock | D | 124 097 | ||||||||
| 2021-07-28 | 3 | Yamada Tadataka By Leslie D. Yamada 2016 Trust | ICVX | Common Stock | I | 627 229 | ||||||||
| 2021-07-28 | 3 | Holtzman Douglas | ICVX | Common Stock | D | 240 982 | ||||||||
| 2021-07-28 | 3 | Richardson Charles E | ICVX | Common Stock | D | 51 133 | ||||||||
| 2021-07-28 | 3 | Simpson Adam K. By family trust | ICVX | Common Stock | I | 781 576 | ||||||||
| 2021-07-28 | 3 | Simpson Adam K. By family trust | ICVX | Common Stock | I | 4 032 | ||||||||
| 2021-07-28 | 3 | Simpson Adam K. By family trust | ICVX | Common Stock | I | 4 032 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
